Product Recalls in Ohio

Product recalls affecting Ohio — including food, drugs, consumer products, medical devices, and vehicles distributed to Ohio. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,807 recalls have been distributed to Ohio in the last 12 months.

55,415 total recalls
2,807 in last 12 months

Showing 901920 of 13,469 recalls

DrugOctober 23, 2024· Lupin Pharmaceuticals Inc.

Recalled Item: Ramipril Capsules USP 5 mg Recalled by Lupin Pharmaceuticals Inc. Due to...

The Issue: CGMP Deviations: Active pharmaceutical ingredient was sourced from an...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2024· Cipla USA, Inc.

Recalled Item: Lanthanum Carbonate Chewable Tablets Recalled by Cipla USA, Inc. Due to...

The Issue: Failed Tablet/Capsule Specifications: Complaints received of crushed and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2024· Cipla USA, Inc.

Recalled Item: Lanthanum Carbonate Chewable Tablets Recalled by Cipla USA, Inc. Due to...

The Issue: Failed Tablet/Capsule Specifications: Complaints received of crushed and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: Morphine Sulfate Extended-Release Tablets 15 mg Recalled by Dr. Reddy's...

The Issue: Failed Impurities/Degradation Specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: Morphine Sulfate Extended-Release Tablets 30 mg Recalled by Dr. Reddy's...

The Issue: Failed Impurities/Degradation Specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 21, 2024· BLI International, Inc.

Recalled Item: Chlorpheniramine Maleate 4 mg tablets Recalled by BLI International, Inc....

The Issue: Superpotent Drug: Stability failure for assay at 6 months test time-point.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 18, 2024· AvKARE

Recalled Item: Sunitinib Malate Capsules Recalled by AvKARE Due to Labeling: Label Mix-Up

The Issue: Labeling: Label Mix-Up

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 18, 2024· AvKARE

Recalled Item: Sunitinib Malate Capsules Recalled by AvKARE Due to Labeling: Label Mix-Up

The Issue: Labeling: Label Mix-Up

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 17, 2024· Keystone Industries

Recalled Item: Perio Maintenance Rinse 0.63% Stannous Fluoride Concentrated Solution...

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 15, 2024· Akron Pharma, Inc.

Recalled Item: OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Recalled by...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 11, 2024· Padagis US LLC

Recalled Item: Triamcinolone Acetonide Cream USP Recalled by Padagis US LLC Due to...

The Issue: Subpotent and Superpotent Drug. Out of specification assay results recorded...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 10, 2024· ACCORD HEALTHCARE, INC.

Recalled Item: Cinacalcet Tablets Recalled by ACCORD HEALTHCARE, INC. Due to CGMP...

The Issue: CGMP Deviations: the presence of a nitrosamine impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 10, 2024· ACCORD HEALTHCARE, INC.

Recalled Item: Cinacalcet Tablets Recalled by ACCORD HEALTHCARE, INC. Due to CGMP...

The Issue: CGMP Deviations: the presence of a nitrosamine impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 10, 2024· ACCORD HEALTHCARE, INC.

Recalled Item: Cinacalcet Tablets 30 mg Recalled by ACCORD HEALTHCARE, INC. Due to CGMP...

The Issue: CGMP Deviations: the presence of a nitrosamine impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 10, 2024· Breckenridge Pharmaceutical, Inc

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Breckenridge Pharmaceutical,...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 9, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: Cinacalcet Tablets Recalled by Dr. Reddy's Laboratories, Inc. Due to CGMP...

The Issue: CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 9, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: Cinacalcet Tablets Recalled by Dr. Reddy's Laboratories, Inc. Due to CGMP...

The Issue: CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 9, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: Cinacalcet Tablets Recalled by Dr. Reddy's Laboratories, Inc. Due to CGMP...

The Issue: CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 8, 2024· C & A Naturistics

Recalled Item: AK Forte Ortiga y Omega 3 Cont. Neto 100 Tabletas Recalled by C & A...

The Issue: Marketed without an Approved NDA/ANDA: FDA analysis found the product to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 1, 2024· ACCORD HEALTHCARE, INC.

Recalled Item: Cisplatin Injection Recalled by ACCORD HEALTHCARE, INC. Due to Failed...

The Issue: Failed Impurities/Degradation Specifications.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund